Answers are grounded in this paper and cite their sources.
Multidrug‐resistant (MDR) Campylobacter jejuni is a foodborne pathogen that threatens public health and food safety. Intestinal colonization is a prerequisite for infection, yet protective commensal bacteria and the potential contributions of microbial metabolites remain poorly defined. This study integrates in vitro co‐culture assays, epithelial cell models, mouse infection experiments, and multi‐omics analyses to identify protective gut commensals and explore potential mechanisms. Most commensal strains tested suppress C. jejuni growth in co‐culture without impairing epithelial cell viability or markedly altering C. jejuni adhesion, indicating that epithelial attachment competition is unlikely to be the dominant protective mechanism. Bacteroides acidifaciens and Bacteroides caecimuris reduce intestinal C. jejuni colonization in mice, alleviate tissue injury, and limit inflammatory responses, with decreased expression of interleukin‐1 beta, interleukin‐6, and tumor necrosis factor‐alpha and increased expression of Occludin, zonula occludens‐1, and mucin‐2. Multi‐omics analyses further show that these strains restore microbial community structure, restrain infection‐associated taxa, and reshape intestinal metabolism. Indole exhibits antibacterial activity against C. jejuni in vitro, with additive effects when combined with propionic acid, syringic acid, or ferulic acid; its contribution to Bacteroides ‐mediated protection in vivo remains unresolved. These findings support further investigation of commensal‐ and metabolite‐based approaches against MDR C. jejuni infection.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: